Overcoming Complex Multi-Strain & Novel Organism Manufacturing Challenges to Enable Scalable Therapeutic Production

• Addressing fermentation, stabilization and scale-up challenges for non-traditional bacterial taxa to ensure consistent large-scale therapeutic manufacturing
• Designing processes for multi-strain consortia with robust quality control frameworks to manage complexity, variability and production costs effectively
• Implementing early manufacturing strategies aligned with clinical development to avoid delays and ensure readiness for late-stage trials

Speakers:

Dan Couto

Chief Operating Officer

Vedanta Biosciences